Home › Degenerasyon ng Macula › Indiana
Pag-aaral pangklinika para sa Degenerasyon ng Macula sa Indiana
7 pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa mga site sa Indiana.
Mga Lungsod sa Indiana
Opisyal na teksto ng pag-aaral (English)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Associated Vitreoretinal and Uveitis Consultants, Carmel
- Midwest Eye Institute, Carmel
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Midwest Eye Institute, Carmel
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Partners Midwest, P.C., Carmel
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Retina Partners Midwest, Carmel
Nagre-recruitPhase 1/2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05197270Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Partners Midwest, P.C. /ID# 262172, Carmel
Nagre-recruitPhase 1/2
Edad 50 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT07160179Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Partners Midwest, PC, Carmel
Nagre-recruitPhase 3
Edad 50 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07064759Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:004, Carmel
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Peb 7, 2025 · NCT06132035Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.